1-3 of 3
Kerry Fenwick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

Ben O'Leary, Rosalind J. Cutts, Yuan Liu, Sarah Hrebien, Xin Huang, Kerry Fenwick, Fabrice André, Sibylle Loibl, Sherene Loi, Isaac Garcia-Murillas, Massimo Cristofanilli, Cynthia Huang Bartlett, Nicholas C. Turner
Journal: Cancer Discovery
Cancer Discov (2018) 8 (11): 1390–1403.
https://doi.org/10.1158/2159-8290.CD-18-0264
Published: 01 November 2018
View articletitled, The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial
Open the PDF for The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial in another window
Includes: Supplementary data
Journal Articles

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina, Maria Teresa Herrera-Abreu, Noelia Tarazona, Clare Peckitt, Elaine Kilgour, Neil R. Smith, Catherine Geh, Claire Rooney, Ros Cutts, James Campbell, Jian Ning, Kerry Fenwick, Amanda Swain, Gina Brown, Sue Chua, Anne Thomas, Stephen R.D. Johnston, Mazhar Ajaz, Katherine Sumpter, Angela Gillbanks, David Watkins, Ian Chau, Sanjay Popat, David Cunningham, Nicholas C. Turner
Journal: Cancer Discovery
Series: Author Choice
Cancer Discov (2016) 6 (8): 838–851.
https://doi.org/10.1158/2159-8290.CD-15-1246
Published: 01 August 2016
View articletitled, High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Open the PDF for High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial in another window
Includes: Supplementary data
Journal Articles

An In Vivo Functional Screen Identifies ST6GalNAc2 Sialyltransferase as a Breast Cancer Metastasis Suppressor

Nirupa Murugaesu, Marjan Iravani, Antoinette van Weverwijk, Aleksandar Ivetic, Damian A. Johnson, Aristotelis Antonopoulos, Antony Fearns, Mariam Jamal-Hanjani, David Sims, Kerry Fenwick, Costas Mitsopoulos, Qiong Gao, Nick Orr, Marketa Zvelebil, Stuart M. Haslam, Anne Dell, Helen Yarwood, Christopher J. Lord, Alan Ashworth, Clare M. Isacke
Journal: Cancer Discovery
Cancer Discov (2014) 4 (3): 304–317.
https://doi.org/10.1158/2159-8290.CD-13-0287
Published: 03 March 2014
View articletitled, An In Vivo Functional Screen Identifies ST6GalNAc2 Sialyltransferase as a Breast Cancer Metastasis Suppressor
Open the PDF for An In Vivo Functional Screen Identifies ST6GalNAc2 Sialyltransferase as a Breast Cancer Metastasis Suppressor in another window
Includes: Multimedia, Supplementary data